MLL/AF4 and AML/MTG8 represent two leukemic fusion genes, which are most frequently found in infant acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), respectively. We examined the influence of MLL/AF4 and AML1/MTG8 fusion genes on the expression of TERT coding for the telomerase protein subunit, and subsequently telomerase activity in t(4;11)-positive ALL and t(8;21)-positive cell lines, respectively. MLL/AF4 suppression diminished telomerase activity and expression of TERT. Blocking pro-apoptotic caspase activation in conjunction with MLL/AF4 knockdown enhanced the inhibition of TERT gene expression, which suggests that MLL/AF4 depletion does not reduce TERT expression levels by inducing apoptosis. Knockdown of HOXA7, a direct transcriptional target of MLL/AF4 fusion gene, caused a reduction of telomerase and TERT to an extent similar to that observed with MLL/AF4 suppression. Chromatin immunoprecipitation of SEM cells, using ectopically expressed FLAG-tagged Hoxa7, indicates HOXA7 binding site in the TERT promoter region. Furthermore, suppression of the AML1/MTG8 fusion gene was associated with severely reduced clonogenicity, induction of replicative senescence, impaired TERT expression and accelerated telomere shortening. We thus present findings that show a mechanistic link between leukemic fusion proteins, essential for development and maintenance of leukemia, and telomerase, a key element of both normal and malignant self-renewal.
Introduction
The concept of tumorigenic leukemic stem cells (LSCs) emerged after a number of studies that found a subgroup of leukemic cells capable of extensive proliferation. 1 The hallmark of LSCs is their ability to self-renew and to generate and maintain the full spectrum of leukemic cell heterogeneity found in a given leukemia. On the basis of this principle, it was hypothesized that most current treatment methods target the descendent bulk of LSCs while leaving the LSC themselves unaffected. Indeed, there is ample evidence to suggest that LSC have a crucial role in therapy resistance and relapse. 2 To acknowledge this, novel treatment approaches targeting aberrant self-renewal of cancer stem cells, including LSCs, are being explored. However, our current understanding of the molecular mechanisms underlying malignant self-renewal is still incomplete. Thus, the development of novel therapies, designed to target the LSC niche, is only just emerging.
Both normal and malignant self-renewal crucially depend on preserving telomeres to maintain genomic integrity and to prevent replicative senescence. 3 Telomere ends are restored by telomerase, a reverse transcriptase consisting of a protein subunit, TERT, and an RNA subunit, TERC (also termed hTR). TERC serves as a template for telomere synthesis and is ubiquitously expressed, whereas, in contrast, transcription of TERT is tightly regulated by transcription factors such as SP1, c-MYC and IRF-4, and is repressed by, for example, the transforming growth factor-b signal transduction pathway. [4] [5] [6] TERT activity is upregulated during cell-cycle activation of immature cells and expression is reduced during cell differentiation. Among the different components of the telomerase ribonucleoprotein complex, TERT is regarded as the ratelimiting component for telomerase activity.
Leukemic fusion genes are generated by chromosomal translocations and are hallmarks of leukemia. Fusion genes, such as AML1/MTG8 (RUNX1/RUNX1T1 or AML1/ETO) or MLL/AF4 (MLL/AFF1 or ALL1/AF4), are exclusively expressed in preleukemic and leukemic cells. The AML1/MTG8 fusion gene is generated from a chromosomal translocation t(8;21) and represents the most common aberration associated with 10-15% of acute myeloid leukemia (AML). This translocation fuses AML1 (or RUNX1), a transcription factor for definitive hemopoiesis, with MTG8 (or RUNXT1), which is part of histone deacetylase-containing complexes. [7] [8] [9] Thus, it converts a transcriptional modulator to a repressor of gene expression by interfering with chromatin modification. In contrast, the chromosomal translocation t(4;11) fuses the MLL gene (mixed lineage leukemia) on chromosome 11 with the AF4 gene on chromosome 4 thereby generating two fusion genes, the derivative 4, AF4/MLL, and the derivative 11, MLL/AF4. [10] [11] [12] This translocation causes an aggressive type of acute lymphoblastic leukemia (ALL), which predominantly affects infants, and is associated with an unfavorable prognosis. 13 Both fusion genes can originate already prenatally. 14, 15 They are key to maintaining a malignant phenotype, hence representing a promising target for new therapeutic approaches. AML/MTG8 and MLL/AF4 are chimeric transcription factors that have been shown to support leukemic self-renewal by impairing hematopoietic differentiation, and by inducing self-renewalassociated signal transduction pathways, and transcriptional programs. [16] [17] [18] [19] [20] Neither of them is sufficient to fully establish leukemia. AML1/MTG8 alone enhances replating efficiency in hematopoietic progenitors, but requires cooperating mutations to induce leukemia. 21 Moreover, two murine MLL/AF4 models yielded only B-cell lymphomas with long latency, 22, 23 whereas ectopic expression of AF4/MLL in murine early hematopoietic stem/progenitor cells caused induced ALL, indicating that t(4;11) leukemia is initiated and maintained by two fusion oncoproteins. 24 Both MLL and MLL/AF4 have been shown to bind to several thousand loci within the genome. 25, 26 The most extensively studied direct transcriptional targets of MLL fusion genes are genes of the Homeobox A (HOXA) cluster. HOXA gene expression is normally downregulated during hematopoietic differentiation. However, analyses have shown high expression levels of select HOXA genes in the majority of MLL-rearranged leukemias, which suggests that the upregulation of HOXA genes may substantially contribute to MLL fusion-driven leukemogenesis and self-renewal. 16, 27 In this study, we used small-interfering RNAs (siRNAs) to investigate the role that two leukemic fusion proteins, MLL/AF4 and AML1/MTG8, have in the control of telomerase and TERT. We show that siRNA-mediated suppression of either fusion protein decreases TERT transcript and protein levels. In addition we show that MLL/AF4 fusion gene regulates TERT expression level through its direct transcriptional target gene, HOXA7. Overall, we show that TERT is part of fusion gene-driven selfrenewal programs. 
Materials and methods

Cell lines
Cell-cycle analysis
Cell-cycle analysis was performed as described. 33 
Real-time RT-PCR
Western blot
Total cellular protein was isolated in parallel with the RNA purification described above. Protein present in the flowthrough of RNeasy columns was precipitated by addition of 2 volumes of acetone and resuspended in urea buffer (9 M urea, 4% (w/w) 3-((3-cholamidopropyl)-dimethylammonio)-propanesulfonate, 1% (w/w) dithiothreitol). For detection of TERT and AML1/MTG8 in Kasumi-1 cells, nuclear and cytosolic extracts were prepared using the NE-PER kit as described by the manufacturer (Pierce/Thermo Fisher, Cramlington, UK). Immunoblots were performed as described. 19, 33 The following antibodies were used for immunoblot detection: MLLT2 (1 mg/ml, C-19; Santa Cruz Biotechnology); RB (500 ng/ml, cat. no. 554136; BD Bioscience Pharmingen, San Jose, CA, USA); underphosphorylated RB (Clone G99-549; BD Bioscience Pharmingen).
RQ-TRAP and flow FISH assay
Real-time quantitative telomeric repeat amplification protocol (RQ-TRAP) assays and flow fluorescent in situ hybridization (FISH) analyses were performed as described. 35, 36 Chromatin immunoprecipitation HOXA7 binding sites were identified using MatInspector (Genomatix, Munich, Germany) using the Matrix Family Library Version 6.0, a core similarity of at least 0.75 and an optimized matrix similarity. SEM cells (10 6 ) were electroporated in 100 ml Nucleofector Kit R (Lonza, Basel, Switzerland) with 2 mg pMSCVpuro-fHOXA7 37 (kindly provided by Robert Slany, University of Erlangen, Germany) or pFhl2-FLAG (gift from Dr Sebastian Raimundo, University of Tuebingen) for 15 ms at 250 V using a Fischer EPI2500 electroporator (Fischer, Heidelberg, Germany). Chromatin immunoprecipitation (ChIP) was performed according to Farnham (http://genomics.ucdavis. edu/farnham/pdf/FarnhamLabChIP%20Protocol.pdf) using inactivated Staphylococcus aureus (Cowan 1 strain, kindly provided by Andreas Peschel, University of Tuebingen) for immunoprecipitation.
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Results
Suppression of MLL/AF4 inhibits telomerase and TERT expression
Suppression of MLL/AF4 by a fusion site-specific siRNA, siMLL/AF4, impaired clonogenic growth and diminished expression of stem cell-associated and self-renewal-associated genes, such as HOXA7, HOXA9 and PROM1 (CD133). 19 We hypothesized that changes in an MLL/AF4-associated self-renewal program will become even more evident upon prolonged depletion of MLL/AF4. Consequently, we repeatedly electroporated t(4;11)-positive SEM cells with siMLL/AF4. This approach routinely yielded a threefold knockdown of MLL/AF4 transcript and protein over a period of up to 6 days (Figures 1a and d) . To control for unspecific and off-target effects, we used two control siRNAs, a mismatch siRNA (siCTL1) or an siRNA suppressing the product of the translocation t(8;21), AML1/MTG8, which has been shown to impair expansion of t(8;21)-positive, but not of t(4;11)-positive, leukemic cells. 19 Because telomerase is a key enzyme for normal and malignant self-renewal, we focused on the impact of the leukemic fusion gene expression on maintaining telomerase activity in leukemic cells. Sustained siRNA-mediated MLL/AF4 depletion correlated with threefold reduced TERT protein levels and a concomitant decrease in telomerase activity (Figures 1a-c) . Concomitantly, analysis of transcript levels by real-time PCR showed that suppression of MLL/AF4 was associated with a more than twofold reduction in TERT transcript levels, whereas TERC was not affected (Figure 1d) .
To exclude the action of MLL/AF4 siRNA on TERT transcript levels as a possible cell-line-specific effect, we extended our study to RS4;11 cells, which express a different MLL/AF4 variant to that of SEM cells. Exon 9 of MLL is fused to exon 4 of AF4 (AFF1) in SEM cells, and is targeted by siMLL/AF4, whereas exon 10-exon 4 variant in RS4;11 cells is targeted by an alternative siRNA, siMLL/AF4-2. 19 Consistent with the fusion site specificity of these siRNAs, siMLL/AF4 diminished MLL/AF4 transcript levels exclusively in SEM cells, and siMLL/AF4-2 only reduced MLL/AF4 in RS4;11 cells (Figures 1e and f) .
siRNA specificity was further shown by the correlation between MLL/AF4 suppression and reduced levels of HOXA7 (Figures 1e and f) . MLL/AF4 knockdown was associated with a twofold reduction in TERT transcript levels (Figures 1e and f) and a concurrent fourfold decrease in telomerase activity in each cell line (Figure 2g ). Overall, these data strongly suggest that MLL/AF4 maintains TERT expression and telomerase activity in t(4;11) positive ALL.
Reduced TERT expression is independent of apoptosis
Prolonged knockdown of MLL/AF4 has been previously shown to increase apoptosis. 19 Because cells with lower TERT levels might be more prone to cell death, 38 we investigated whether apoptosis-related loss of siMLL/AF4-transfected cells may cause us to underestimate the extent of TERT reduction. Alternatively, diminished TERT gene expression may have been a consequence of apoptosis. To examine the influence of apoptosis on TERT transcript levels, we combined siRNA electroporation with a pan-caspase inhibitor, zVAD-FMK. zVAD diminished the fraction of subG1 cells, tenfold, to background levels ( Figure 2a ) indicating a complete inhibition of apoptosis. Neither electroporation alone nor electroporation with the control siRNA, siAML1/MTG8, caused caspase activation or induced significant cell death compared to untreated SEM cells. As in previous experiments, siMLL/AF4 reduced TERT expression levels twofold (Figure 2b) . Addition of zVAD caused a further decrease down to o10% of TERT control levels, but did not enhance MLL/AF4 knockdown nor deplete the direct MLL/AF4 target, HOXA7 (Figure 2b ). Combining zVAD with mock (siRNA absent) or siAML1/MTG8 electroporation did not alter MLL/AF4, HOXA7 or TERT levels. Thus, enhanced TERT depletion is unlikely a result of an increased apoptosis of MLL/AF4-depleted cells. Instead, caspase inhibition itself may directly or indirectly facilitate MLL/AF4-dependent TERT downmodulation.
HOXA7 controls TERT ChIP sequencing analysis of t(4;11)-positive SEM cells found histone H3K4 trimethylation and H3K79 dimethylation patterns, indicators of transcriptional activity, in the TERT locus. However, concomitant MLL/AF4 occupancy had not been detected. 26 Hence, the dependence of TERT expression on t(4;11)-positive cell lines is unlikely to be directly linked to MLL/AF4. Instead, genes downstream of MLL/AF4 seem to control TERT.
On the basis of previous findings from ChIP-sequencing assays of SEM cells showing that MLL/AF4 occupies the chromosomal region from HOXA7 to HOXA10, 26 we examined the impact of MLL/AF4 depletion on HOXA gene cluster expression. MLL/AF4 knockdown reduced HOXA6 transcript levels threefold, HOXA7 sixfold, HOXA9 twofold and HOXA10 fivefold (Figure 3a) . Concurrently, HOXA6, HOXA7 and HOXA9 protein levels also decreased three-to fivefold (Figure 3b) . Analysis of TERT gene expression showed that the t(4;11) ALL lines SEM and RS4;11 contain five-tenfold higher-TERT transcript levels than the t(4;11) AML line MV4;11 and the t(8;21) AML line Kasumi-1 (Figure 3c ). This pattern coincided with the expression pattern of HOXA6 and HOXA7 in these four lines, whereas HOXA9 and HOXA10 were expressed to similar extends (Figures 3d-g ). Kasumi-1 showed comparably low expression levels of all four HOXA genes examined (Figures 3d-g ).
Because there is an existing correlation between HOXA7 and TERT expression levels, we examined the possible influence of HOXA7 on telomerase activity and on TERT expression. Electroporation of SEM and RS4;11 cells with HOXA7 siRNA induced a twofold reduction of HOXA7 transcript levels ( Figures  4a and b) . Concomitantly, decreased TERT transcript levels (Figures 4a and b) and impaired telomerase activity (Figures 4c  and d) was observed in both cell lines. Electroporation of SEM cells with an alternative HOXA7 siRNA, siHOXA7-8, also reduced TERT expression (Figure 4e) .
In contrast, MLL/AF4 expression was not affected by HOXA7 siRNA in either cell line (Figures 4a, b and e) , which suggests that HOXA7 regulates TERT expression downstream of MLL/ AF4. Interestingly, knockdown of HOXA7 is associated with an almost twofold decrease in the transcript levels of HOXA6 and HOXA10 (Figure 4f ), an effect similarly reported after HOXA9 knockdown; HOXA7 and HOXA10 transcript levels reduced concurrently. 27 Thus, a role for other late HOXA members in TERT regulation cannot be excluded.
HOXA7 binds to the TERT locus
To establish whether TERT gene expression is directly regulated by HOXA7, we investigated the TERT promoter for putative HOX binding sites. Using MatInspector, we identified three possible binding sites for HOXA members 1.5, 1.2 and 0.7 kb upstream of the transcriptional initiation site (Figure 5a ). We performed ChIP experiments with transiently expressed FLAG-tagged murine Hoxa7 to examine intracellular HOXA7 binding to TERT promoter sites in SEM cells. FLAG-tagged murine Hoxa7 was used because of a lack of HOXA7 antibodies suitable for ChIP. FLAG-tagged Fhl2 served as a specificity control. The putative HOXA binding sites mapped around À1.3 and À0.7 kb in the TERT gene and were named regions I and II, respectively. The analysis showed FLAG-Hoxa7 binding to region I, but not to region II (Figure 5b ), suggesting that human HOXA7 binds to the region between À1 and À1.5 kb.
Knockdown of AML1/MTG8 fusion gene expression reduces TERT
We investigated whether the downstream effect of MLL/AF4 on TERT also applies to other leukemic fusion genes, such as AML1/ MTG8 in t(8;21)-positive AML. Similar to MLL/AF4, siRNAmediated suppression of AML1/MTG8 impairs the maintenance of the leukemic phenotype, both in cell culture and in a xenotransplantation model. 17, 33, 39 Indeed, AML1/MTG8 knockdown greatly reduced leukemic clonogenicity in t(8;21)-positive Kasumi-1 cells indicating a compromised leukemic selfrenewal (Figure 6a ). In addition, prolonged AML1/MTG8 depletion over a period of 7-12 days caused elevated levels of the CDK inhibitor p27 KIP1 (CDKN1B), hypophosphorylation of RB and a sixfold increase in cells positive for senescenceassociated b-galactosidase (Figures 6b and c) .
Flow FISH analyses have shown that AML cells with chromosomal abnormalities have particularly short telomeres, but substantially increased TERT levels compared to cells with normal karyotype. 40 In agreement with these observations, Kasumi-1 cells have very short mean telomere lengths of o3 kb (Figures 6d) . Notably, AML1/MTG8 knockdown resulted in a further telomere shortening by 30%, indicating that AML1/ MTG8 is involved in telomere maintenance. Furthermore, it implicates that the observed senescent phenotype may be of replicative nature. We hypothesized that this telomere attrition maybe attributable to a link between AML1/MTG8 and telomerase. Thus, we examined TERT transcript and protein levels in siRNA-mediated suppression of AML1/MTG8-expressing Kasumi-1 cells. Knockdown of AML1/MTG8 correlated with a more than twofold reduction in TERT transcript levels in both Kasumi-1 and SKNO-1 cells, a second t(8;21)-positive AML line (Figures 6e and f) . Interestingly, in contrast to the nuclear localization of AML1/MTG8, TERT protein showed a predominantly cytosolic distribution in Kasumi-1 cells. However, depletion of AML1/MTG8 protein coincided with a decrease 
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A Gessner et al in TERT protein levels in both cellular compartments (Figure 6g ). Conducive with cell line specificity of fusion gene-specific siRNAs, siAML1/MTG8 did not affect TERT expression in MLL/ AF4-expressing SEM cells and siMLL/AF4 had no effect on TERT expression in Kasumi-1 cells lacking MLL/AF4 (Figures 1b, d, 2b and 6e-g). Unlike in MLL/AF4-expressing SEM cells, none of the HOXA7 siRNAs affected TERT in AML1/MTG8-expressing Kasumi-1 cells, despite causing a twofold reduction of HOXA7 in these cells (Figure 6h ). This lack of effect may be explained by the finding that Kasumi-1 cells express only very low transcript levels of HOXA7 and other HOXA members (Figures 3d-g ). Thus, HOXA7 has no influence over the regulation of TERT expression in AML1/MTG8-positive cells. Overall, AML1/MTG8 regulates leukemic self-renewal and expansion by controlling the expression of TERT independently of HOXA7 levels.
Discussion
Leukemic fusion genes, coding for transcription factors, not only inhibit differentiation but support pre-leukemic and leukemic cell proliferation and clonogenicity. Here we show that the two fusion genes, MLL/AF4 and AML1/MTG8, maintain TERT expression, thus establishing a functional link between a leukemic fusion oncogene and a key component of the selfrenewal program. Furthermore, we show that HOXA7, a direct transcriptional target of MLL/AF4, regulates TERT.
By using RNA interference and implementing fusion genespecific siRNAs, we found that knockdown of MLL/AF4 and AML1/MTG8 reduced TERT transcript levels more than twofold, which corresponded with the reduced telomerase activity observed. In addition, senescence-associated characteristics, Fusion genes control TERT A Gessner et al such as b-galactosidase and telomere shortening, were observed after AML1/MTG8 depletion. We recently reported similar findings after prolonged siRNA-mediated depletion of AML1/ MTG8, which lead to a cell-cycle arrest in G1 and subsequently to cellular senescence. 33 Because telomerase restores telomere ends and prevents replicative senescence, we consider the senescenceassociated characteristics to be attributable to the reduced TERT protein levels reported. Similarly, Ewing sarcoma-associated fusion proteins (that is, EWS/FLI1) also influenced TERT protein levels and interfered with the development senescence in Ewing sarcoma. 41, 42 Maintaining TERT expression and preventing replicative senescence may be a mechanism shared by many fusion genes to support malignant self-renewal. Given the influence fusion genes have on TERT expression, and because fusion-driven leukemogenesis is an early initiating event, it is thought that self-renewal mechanisms were compromised at a very early stage in leukemia development. Indeed, in a previous study, ectopic expression of AML1/MTG8 led to the self-renewal of immature human hematopoietic stem/progenitor cells, and was associated with ongoing telomerase activity and maintained telomere lengths compared to control cells. 18 TERT expression is unlikely to be controlled by either MLL/ AF4 or AML1/MTG8 fusion genes directly. Because the AML1/MTG8 fusion protein acts mainly as a transcriptional repressor, 7, 8 the parallel reduction of AML1/MTG8 and TERT levels suggests TERT being an indirect transcriptional target for this fusion protein. In contrast, MLL/AF4 activates transcription and enhances gene expression by the recruitment of a histone H3K79 methyltransferase, DOT1L, which catalyzes the dimethylation of histone H3 Lys 79 (H3K79me2) at the promoter sites of target genes such HOXA9. 43 Although global ChIP analysis found that the TERT gene displays an H3K4me3 and H3K79me2 signature in t(4;11)-positive SEM cells, indicative of active TERT expression, it failed to identify any direct interaction of MLL or MLL/AF4 with the TERT gene. 26 Possible mediators of MLL/AF4-exerted control of telomerase are members of the HOXA cluster, which are direct transcriptional targets of this fusion protein. 2 Upregulation of HOXA genes are thought to be essential for leukemic transformation and self-renewal by most MLL fusion genes. 37, 44, 45 Global gene expression analyses, in both murine models and in human leukemias, regard HOXA9 and HOXA10 and, to a somewhat lesser extent, HOXA7 as a signature of stemness. 16, 27, [46] [47] [48] Indeed, continuous HOXA expression has been found to block differentiation and to promote leukemic cell expansion. 49 Moreover, transcriptional activation of Meis1 in combination with either Hoxa7 or Hoxa9 promoted leukemogenesis in mice. 50 However, despite their established role in leukemic transformation and self-renewal, only a few target genes have been identified for HOXA9 and HOXA10, [51] [52] [53] and hardly any for HOXA7. 54 In our study, a reduction in telomerase activity and TERT transcript levels was observed when HOXA7 was silenced in MLL/AF4 cells, suggesting HOXA7 as a mediator of MLL/AF4-exerted control of TERT expression. In concordance with this finding, ChIP analysis showed that murine Hoxa7 binds to the TERT promoter. Thus, TERT is a direct target gene for HOXA7. However, we cannot rule out that MLL/AF4 may also control TERT in a HOXA7-independent manner. Moreover, two different studies have shown that a substantial fraction of t(4;11)-positive ALLs show no deregulated HOXA expression. 55, 56 Although low expression levels of, for example, HOXA7 does not prove its irrelevance for the leukemic phenotype, it nevertheless implies that HOXA7 may not regulate TERT in this subset of (4;11)-positive ALLs.
In contrast to MLL/AF4, HOXA7 does not have a role in the regulation of TERT by AML1/MTG8. HOXA7 siRNAs had no Fusion genes control TERT A Gessner et al effect on TERT transcript levels in AML1/MTG8-expressing Kasumi-1 cells, which are a good control to rule out a possible off-target effect of siRNAs being responsible for the reduction of TERT expression in MLL/AF4-expressing SEM and RS4;11 cells. This result correlates with the very low expression of the posterior HOXA genes observed in t(8;21)-positive AML cells. 57 Because TERT expression has been found to be tightly linked to S phase of the cell cycle, and mediated by the RB-E2F axis, 58 it may be tempting to speculate that AML1/MTG8 maintains telomerase activity by exploiting RB-mediated TERT expression. Indeed, AML/1MT8G knockdown results in elevated levels of the CDK inhibitor p27 KIP1 and hypophosphorylation of RB, indicative of cellular senescence. 33 Sustained TERT expression and telomerase activity is likely to be one mechanism by which fusion gene-encoded transcription factors drive malignant self-renewal. Although expression of TERT/telomerase is necessary for human stem cells, its expression alone is not sufficient to maintain self-renewal. It is instead likely that these fusion genes manipulate a larger core program in cancer stem cell maintenance, with TERT being a prominent member of it. A functional comparison of the role that fusion genes have in self-renewal will help to further elucidate this program, and explore its therapeutic implications.
In conclusion, two leukemic fusion genes, MLL/AF4 and AML1/MTG8, associated with impaired differentiation and selfrenewal, sustain TERT expression. We have thus found a link between leukemic transcriptional programs and a key factor for self-renewal. These results provide further proof of the significance in fusion genes for leukemic self-renewal and maintenance. Consequently, manipulating leukemic cell maintenance by interfering with the function of fusion genes, such as MLL/AF4 or AML1/MTG8, may represent a future novel therapeutic target that could improve the clinical outcome of leukemia patients. 59 
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